跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,408 条关于
“Akt pathway”
全部
12,408
临床试验
5,219
药物
663
机构
89
资讯
6,437
7个月前
Sensei Biotherapeutics Acquires Faeth Therapeutics for $200M to Advance PI3K/AKT/mTOR Pathway Inhibitor PIKTOR
4个月前
Real-World Study Reveals Lower Hyperglycemia Management Burden with Capivasertib Versus Alpelisib in Metastatic Breast Cancer
去年
Capivasertib Causes Distinctive Glucose Spikes in Breast Cancer Patient, Prompting Japanese Safety Warning
去年
Faeth Therapeutics Advances Novel Three-Pronged Approach for Metabolism-Driven Cancers with Promising Preclinical Results
去年
PostMONARCH Trial: Abemaciclib Plus Fulvestrant Improves PFS in HR+/HER2- Advanced Breast Cancer
去年
Truqap plus Abiraterone and ADT Improves rPFS in PTEN-Deficient Metastatic Hormone-Sensitive Prostate Cancer
去年
Capivasertib Shows Promise in ER+/HER2- Metastatic Breast Cancer with PIK3CA Mutations
4年前
Advances in PARP Inhibitor Combinations Show Promise for Ovarian Cancer Treatment
去年
Capivasertib Plus Abiraterone Extends Radiographic Progression-Free Survival in PTEN-Deficient mHSPC
上个月
Advanced Endometrial Cancer Pipeline Gains Momentum as ADCs, Immunotherapy and Targeted Combinations Reshape Treatment
第 1 页,共 644 页
上一页
下一页